首页> 外国专利> Use of pharmaceutical formulation comprising matrix e.g. polysaccharides cellulose and dextran, with protein adsorptive properties, for the prevention or alleviation of symptoms by volatile body sensitizer, infectious or toxic impurities

Use of pharmaceutical formulation comprising matrix e.g. polysaccharides cellulose and dextran, with protein adsorptive properties, for the prevention or alleviation of symptoms by volatile body sensitizer, infectious or toxic impurities

机译:包含基质的药物制剂的用途,例如具有蛋白质吸附特性的多糖纤维素和右旋糖酐,用于通过挥发性的身体敏感剂,传染性或有毒杂质预防或减轻症状

摘要

Use of pharmaceutical formulation comprising a matrix with protein adsorptive properties that can adhere to volatile impurities, for the prevention or alleviation of symptoms by volatile body sensitizer, infectious or toxic impurities, is claimed, where the formulation is suitable for intranasal application, and as a barrier for preventing or reducing systemic absorption of impurities in the body. ACTIVITY : Antiallergic; Antiasthmatic; Antimicrobial; Antidote. MECHANISM OF ACTION : None given.
机译:本发明要求包含具有可吸附到挥发性杂质上的蛋白质吸附特性的基质的药物制剂用于通过挥发性身体敏化剂,传染性或毒性杂质预防或减轻症状的用途,其中该制剂适合鼻内应用,并且作为药物。防止或减少体内杂质吸收的屏障。活性:抗过敏;抗哮喘抗菌;解毒剂。作用机理:未给出。

著录项

  • 公开/公告号DE102008020387A1

    专利类型

  • 公开/公告日2009-10-29

    原文格式PDF

  • 申请/专利权人 LIEDTKE RAINER K.;

    申请/专利号DE20081020387

  • 发明设计人 LIEDTKE RAINER K.;

    申请日2008-04-23

  • 分类号A61K9;A61K9/06;A61K9/10;A61K9/14;A61P37/08;A61P11/06;A61P31;A61K9/12;

  • 国家 DE

  • 入库时间 2022-08-21 19:09:09

相似文献

  • 专利
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号